153 related articles for article (PubMed ID: 7103443)
1. Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humans.
Laskin OL; Longstreth JA; Saral R; de Miranda P; Keeney R; Lietman PS
Antimicrob Agents Chemother; 1982 Mar; 21(3):393-8. PubMed ID: 7103443
[TBL] [Abstract][Full Text] [Related]
2. Single-dose pharmacokinetics of acyclovir.
Spector SA; Connor JD; Hintz M; Quinn RP; Blum MR; Keeney RE
Antimicrob Agents Chemother; 1981 Apr; 19(4):608-12. PubMed ID: 7247383
[TBL] [Abstract][Full Text] [Related]
3. Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans.
Laskin OL; de Miranda P; King DH; Page DA; Longstreth JA; Rocco L; Lietman PS
Antimicrob Agents Chemother; 1982 May; 21(5):804-7. PubMed ID: 7103460
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir kinetics in end-stage renal disease.
Laskin OL; Longstreth JA; Whelton A; Rocco L; Lietman PS; Krasny HC; Keeney RE
Clin Pharmacol Ther; 1982 May; 31(5):594-601. PubMed ID: 7075109
[TBL] [Abstract][Full Text] [Related]
5. Acyclovir clinical pharmacology. An overview.
Lietman PS
Am J Med; 1982 Jul; 73(1A):193-6. PubMed ID: 7048912
[TBL] [Abstract][Full Text] [Related]
6. Metabolic fate of radioactive acyclovir in humans.
de Miranda P; Good SS; Krasny HC; Connor JD; Laskin OL; Lietman PS
Am J Med; 1982 Jul; 73(1A):215-20. PubMed ID: 7102704
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.
Whitley RJ; Blum MR; Barton N; de Miranda P
Am J Med; 1982 Jul; 73(1A):165-71. PubMed ID: 7102700
[TBL] [Abstract][Full Text] [Related]
8. Disposition of intravenous radioactive acyclovir.
de Miranda P; Good SS; Laskin OL; Krasny HC; Connor JD; Lietman PS
Clin Pharmacol Ther; 1981 Nov; 30(5):662-72. PubMed ID: 7297024
[TBL] [Abstract][Full Text] [Related]
9. Acyclovir kinetics after intravenous infusion.
de Miranda P; Whitley RJ; Blum MR; Keeney RE; Barton N; Cocchetto DM; Good S; Hemstreet GP; Kirk LE; Page DA; Elion GB
Clin Pharmacol Ther; 1979 Dec; 26(6):718-28. PubMed ID: 227639
[TBL] [Abstract][Full Text] [Related]
10. Overview of acyclovir pharmacokinetic disposition in adults and children.
Blum MR; Liao SH; de Miranda P
Am J Med; 1982 Jul; 73(1A):186-92. PubMed ID: 7048911
[TBL] [Abstract][Full Text] [Related]
11. Treatment of herpes virus infections in immunocompromised patients with acyclovir by continuous intravenous infusion.
Spector SA; Hintz M; Wyborny C; Connor JD; Keeney RE; Liao S
Am J Med; 1982 Jul; 73(1A):275-80. PubMed ID: 6285719
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir concentrations and tolerance during repetitive administration for 18 days.
Laskin OL; Saral R; Burns WH; Angelopulos CM; Lietman PS
Am J Med; 1982 Jul; 73(1A):221-4. PubMed ID: 7048913
[TBL] [Abstract][Full Text] [Related]
13. The tolerance to and pharmacokinetics of penciclovir (BRL 39,123A), a novel antiherpes agent, administered by intravenous infusion to healthy subjects.
Fowles SE; Pierce DM; Prince WT; Staniforth D
Eur J Clin Pharmacol; 1992; 43(5):513-6. PubMed ID: 1336464
[TBL] [Abstract][Full Text] [Related]
14. Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure.
Krasny HC; Liao SH; de Miranda P; Laskin OL; Whelton A; Lietman PS
Am J Med; 1982 Jul; 73(1A):202-4. PubMed ID: 7102703
[TBL] [Abstract][Full Text] [Related]
15. Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient.
Yang HH; Hsiao YP; Shih HC; Yang JH
Int J Dermatol; 2007 Aug; 46(8):883-4. PubMed ID: 17651180
[TBL] [Abstract][Full Text] [Related]
16. Effect of renal failure on the pharmacokinetics of acyclovir.
Laskin OL; Longstreth JA; Whelton A; Krasny HC; Keeney RE; Rocco L; Lietman PS
Am J Med; 1982 Jul; 73(1A):197-201. PubMed ID: 7102702
[No Abstract] [Full Text] [Related]
17. Metabolic disposition of acyclovir in the guinea pig, rabbit, and monkey.
Good SS; de Miranda P
Am J Med; 1982 Jul; 73(1A):91-5. PubMed ID: 7102713
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis.
Van Dyke RB; Connor JD; Wyborny C; Hintz M; Keeney RE
Am J Med; 1982 Jul; 73(1A):172-5. PubMed ID: 7102701
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bioavailability of acyclovir in the dog.
Krasny HC; de Miranda P; Blum MR; Elion GB
J Pharmacol Exp Ther; 1981 Feb; 216(2):281-8. PubMed ID: 7463350
[TBL] [Abstract][Full Text] [Related]
20. Human pharmacokinetics of acyclovir (an antiviral agent) following rapid intravenous injection.
Brigden D; Bye A; Fowle AS; Rogers H
J Antimicrob Chemother; 1981 Apr; 7(4):399-404. PubMed ID: 7251524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
